肝脏特定的MDM2反感性寡核酸的输送抵消了饮食诱导的代谢功能障碍相关的脂肪性肝病
Md Moinul Hoque1, Mengjie Kong1, Xinyi Yuan1
1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China.
一种针对肝脏小鼠双分钟2 (MDM2) 的新药显示出治疗代谢功能障碍相关的脂肪性肝病 (MASLD) 的前景. 在小鼠模型中,GalNAc-Mdm2ASO疗法改善了肝脏健康和相关的代谢问题.
科学领域:
- 肝病学和代谢疾病
- 药物开发和治疗学
- 分子生物学分子生物学
背景情况:
- 由于治疗选择有限,代谢功能障碍相关的脂肪性肝病 (MASLD) 存在重大未满足的医疗需求.
- 肝脏小鼠双分钟2 (MDM2) 在MASLD患者中被上调,其抑制在临床前模型中显示出治疗潜力.
- 现有的MASLD小鼠模型需要进一步研究新型治疗剂.
研究的目的:
- 在MASLD中评估针对MDM2 (GalNAc-Mdm2ASO) 的新型肝细胞特异性GalNAc结合抗感寡核酸的治疗疗效.
- 评估GalNAc-Mdm2ASO对不同饮食诱导的MASLD小鼠模型中肝损伤,脂肪,纤维化和相关代谢功能障碍的影响.
- 阐明在MASLD中MDM2抑制的肝保护作用背后的分子机制.
主要方法:
- 在高脂肪高胆固醇 (HFHC) 和胆固醇缺乏,L-氨基酸定义,高脂肪饮食 (CDAHFD) 诱导的MASLD小鼠模型中开发和管理GalNAc-Mdm2ASO.
- 综合评估肝脏组织学,肥胖症,炎症,纤维化和生物化学参数,包括脂质和葡萄糖代谢.
- 分析肝脏脂质物种 (胆固醇,二糖醇,胺,甘油三) 的积累,以了解治疗效应.
主要成果:
- 在HFHC模型中,GalNAc-Mdm2ASO治疗显著缓解了肝损伤,脂肪,纤维化,胰岛素抵抗和高脂血症.
- 在HFHC模型中,治疗减少了胆固醇,二甲基甘油和胺的肝脏积累,这是MASLD的关键驱动因素.
- 在CDAHFD模型中,GalNAc-Mdm2ASO减轻了肝炎,胆固醇积累和纤维化,尽管三糖积累不受影响.
结论:
- 使用GalNAc-Mdm2ASO的肝脏MDM2抑制表明对MASLD具有显著的治疗潜力.
- 该药物有效地改善了两个不同的MASLD小鼠模型中的关键病理特征和代谢障碍.
- GalNAc-Mdm2ASO代表了一种有前途的新疗法策略,用于管理与代谢功能障碍相关的脂肪性肝病.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
相关概念视频
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Gross Anatomy of the Liver
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is...
